M

Merck

Organization

Heard in 159 episodes across 55 shows since Sep 2025

Merck & Co., known as MSD outside the United States and Canada, is a global pharmaceutical company that develops and markets prescription medicines, vaccines, and biologic therapies.

Discussed inMarkets73%Business11%Politics9%AI & Tech7%

Episodes

159
across 55 shows

This week

0
episodes on 0 shows

Expert statements

19
16 positive

Share of the conversation

Mentions of Merck per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.2‰0.4‰0.6‰0.8‰Aug 15Sep 6Sep 29Oct 21Nov 12
Show the data
DayShare (7-day)Mentions
Sep 250.04‰2
Sep 280.04‰2
Sep 300.04‰1
Oct 10.08‰4
Oct 50.06‰2
Oct 60.08‰2
Oct 90.07‰4
Oct 100.08‰1
Oct 130.06‰2
Oct 140.08‰2
Oct 150.11‰4
Oct 160.09‰2
Oct 180.10‰1
Oct 190.10‰1
Oct 200.09‰1
Oct 220.06‰2
Oct 230.09‰6
Oct 250.09‰1
Oct 260.12‰4
Oct 270.13‰3
Oct 290.14‰2
Oct 300.11‰3
Oct 310.13‰2
Nov 10.13‰1
Nov 20.13‰4
Nov 30.12‰2
Nov 90.02‰1
Nov 100.02‰1
Nov 110.02‰1
Nov 120.04‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Merck comes up on a podcast

One email a week at most, with the new episodes that mention Merck. Free, no account needed, unsubscribe in one click.

What experts have said about Merck

19 statements · 16 positive · 3 mixed

  1. Jim CramerPositiveNov 10, 2026· Mad Money w/ Jim Cramer

    Merck remains a good long-term holding.

    “100% a good hold.”

    Listen at 9:16

    Open the episode · NVIDIA Risk, Anthropic IPO Test, and Texas Roadhouse Rally
  2. Jared HolzPositiveOct 22, 2026· CNBC's "Fast Money"

    Merck is attractive for investors bullish on the cancer-vaccine prospects.

    “Merck is actually somewhat compelling here, I think, if you're actually bullish on the prospects.”

    Listen at 28:48

    Open the episode · Tech Tumbles In Market Sell-Off… And Moderna’s Meltdown After Data Leak 10/22/26
  3. Jim CramerPositiveOct 9, 2026· Mad Money w/ Jim Cramer

    Merck is currently performing very well

    “I think that they are doing incredibly well.”

    Listen at 31:19

    Open the episode · Mad Money w/ Jim Cramer 10/9/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

159 episodes featuring Merck, newest first